[(2R,3R,4S,5R,6S)-3,4,5-triacetyloxy-6-[(4Z)-1-(4-chlorophenyl)-4-[[4-(dimethylamino)phenyl]methylidene]-5-oxoimidazol-2-yl]sulfanyloxan-2-yl]methyl acetate

C32H34ClN3O10S — CID 10604634

IUPAC[(2R,3R,4S,5R,6S)-3,4,5-triacetyloxy-6-[(4Z)-1-(4-chlorophenyl)-4-[[4-(dimethylamino)phenyl]methylidene]-5-oxoimidazol-2-yl]sulfanyloxan-2-yl]methyl acetate
SMILESCC(=O)OC[C@H]1O[C@@H](SC2=N/C(=C\c3ccc(N(C)C)cc3)C(=O)N2c2ccc(Cl)cc2)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O
InChIInChI=1S/C32H34ClN3O10S/c1-17(37)42-16-26-27(43-18(2)38)28(44-19(3)39)29(45-20(4)40)31(46-26)47-32-34-25(15-21-7-11-23(12-8-21)35(5)6)30(41)36(32)24-13-9-22(33)10-14-24/h7-15,26-29,31H,16H2,1-6H3/b25-15-/t26-,27-,28+,29-,31+/m1/s1
InChIKeyAYCKRLMJHKGQRG-ONQLOPSHSA-N
MW688.16 g/mol
LogP3.97
Rot. Bonds9

About [(2R,3R,4S,5R,6S)-3,4,5-triacetyloxy-6-[(4Z)-1-(4-chlorophenyl)-4-[[4-(dimethylamino)phenyl]methylidene]-5-oxoimidazol-2-yl]sulfanyloxan-2-yl]methyl acetate

[(2R,3R,4S,5R,6S)-3,4,5-triacetyloxy-6-[(4Z)-1-(4-chlorophenyl)-4-[[4-(dimethylamino)phenyl]methylidene]-5-oxoimidazol-2-yl]sulfanyloxan-2-yl]methyl acetate (PubChem CID 10604634) has the molecular formula C32H34ClN3O10S and a molecular weight of 688.16 g/mol. Its IUPAC name is [(2R,3R,4S,5R,6S)-3,4,5-triacetyloxy-6-[(4Z)-1-(4-chlorophenyl)-4-[[4-(dimethylamino)phenyl]methylidene]-5-oxoimidazol-2-yl]sulfanyloxan-2-yl]methyl acetate.

Molecular Properties

Compound Name[(2R,3R,4S,5R,6S)-3,4,5-triacetyloxy-6-[(4Z)-1-(4-chlorophenyl)-4-[[4-(dimethylamino)phenyl]methylidene]-5-oxoimidazol-2-yl]sulfanyloxan-2-yl]methyl acetate
PubChem CID10604634
Molecular FormulaC32H34ClN3O10S
Molecular Weight688.16 g/mol
Exact Mass687.17
IUPAC Name[(2R,3R,4S,5R,6S)-3,4,5-triacetyloxy-6-[(4Z)-1-(4-chlorophenyl)-4-[[4-(dimethylamino)phenyl]methylidene]-5-oxoimidazol-2-yl]sulfanyloxan-2-yl]methyl acetate
SMILESCC(=O)OC[C@H]1O[C@@H](SC2=N/C(=C\c3ccc(N(C)C)cc3)C(=O)N2c2ccc(Cl)cc2)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O
InChIInChI=1S/C32H34ClN3O10S/c1-17(37)42-16-26-27(43-18(2)38)28(44-19(3)39)29(45-20(4)40)31(46-26)47-32-34-25(15-21-7-11-23(12-8-21)35(5)6)30(41)36(32)24-13-9-22(33)10-14-24/h7-15,26-29,31H,16H2,1-6H3/b25-15-/t26-,27-,28+,29-,31+/m1/s1
InChIKeyAYCKRLMJHKGQRG-ONQLOPSHSA-N
XLogP3.97
TPSA150.34 Ų
H-Bond Donors
H-Bond Acceptors13
Rotatable Bonds9
Heavy Atoms47
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500688.16
LogP ≤ 53.97
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1013

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'anil_di_alk_B(251)', 'substructure': 'N/A'}, {'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze [(2R,3R,4S,5R,6S)-3,4,5-triacetyloxy-6-[(4Z)-1-(4-chlorophenyl)-4-[[4-(dimethylamino)phenyl]methylidene]-5-oxoimidazol-2-yl]sulfanyloxan-2-yl]methyl acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(2R,3R,4S,5R,6S)-3,4,5-triacetyloxy-6-[(4Z)-1-(4-chlorophenyl)-4-[[4-(dimethylamino)phenyl]methylidene]-5-oxoimidazol-2-yl]sulfanyloxan-2-yl]methyl acetate?
The IUPAC name of [(2R,3R,4S,5R,6S)-3,4,5-triacetyloxy-6-[(4Z)-1-(4-chlorophenyl)-4-[[4-(dimethylamino)phenyl]methylidene]-5-oxoimidazol-2-yl]sulfanyloxan-2-yl]methyl acetate (CID 10604634) is [(2R,3R,4S,5R,6S)-3,4,5-triacetyloxy-6-[(4Z)-1-(4-chlorophenyl)-4-[[4-(dimethylamino)phenyl]methylidene]-5-oxoimidazol-2-yl]sulfanyloxan-2-yl]methyl acetate.
What is the SMILES notation for [(2R,3R,4S,5R,6S)-3,4,5-triacetyloxy-6-[(4Z)-1-(4-chlorophenyl)-4-[[4-(dimethylamino)phenyl]methylidene]-5-oxoimidazol-2-yl]sulfanyloxan-2-yl]methyl acetate?
The canonical SMILES for [(2R,3R,4S,5R,6S)-3,4,5-triacetyloxy-6-[(4Z)-1-(4-chlorophenyl)-4-[[4-(dimethylamino)phenyl]methylidene]-5-oxoimidazol-2-yl]sulfanyloxan-2-yl]methyl acetate is CC(=O)OC[C@H]1O[C@@H](SC2=N/C(=C\c3ccc(N(C)C)cc3)C(=O)N2c2ccc(Cl)cc2)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O.
What is the InChIKey of [(2R,3R,4S,5R,6S)-3,4,5-triacetyloxy-6-[(4Z)-1-(4-chlorophenyl)-4-[[4-(dimethylamino)phenyl]methylidene]-5-oxoimidazol-2-yl]sulfanyloxan-2-yl]methyl acetate?
The InChIKey is AYCKRLMJHKGQRG-ONQLOPSHSA-N. The full InChI is InChI=1S/C32H34ClN3O10S/c1-17(37)42-16-26-27(43-18(2)38)28(44-19(3)39)29(45-20(4)40)31(46-26)47-32-34-25(15-21-7-11-23(12-8-21)35(5)6)30(41)36(32)24-13-9-22(33)10-14-24/h7-15,26-29,31H,16H2,1-6H3/b25-15-/t26-,27-,28+,29-,31+/m1/s1.
What are the key properties of [(2R,3R,4S,5R,6S)-3,4,5-triacetyloxy-6-[(4Z)-1-(4-chlorophenyl)-4-[[4-(dimethylamino)phenyl]methylidene]-5-oxoimidazol-2-yl]sulfanyloxan-2-yl]methyl acetate?
[(2R,3R,4S,5R,6S)-3,4,5-triacetyloxy-6-[(4Z)-1-(4-chlorophenyl)-4-[[4-(dimethylamino)phenyl]methylidene]-5-oxoimidazol-2-yl]sulfanyloxan-2-yl]methyl acetate has a molecular weight of 688.16 g/mol, XLogP of 3.97, 9 rotatable bonds, 0 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for [(2R,3R,4S,5R,6S)-3,4,5-triacetyloxy-6-[(4Z)-1-(4-chlorophenyl)-4-[[4-(dimethylamino)phenyl]methylidene]-5-oxoimidazol-2-yl]sulfanyloxan-2-yl]methyl acetate is sourced from PubChem (CID 10604634), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).